X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Journal of Zhejiang University-SCIENCE B

期刊標題檢索 J ZHEJIANG UNIV 最新評論: Review speed: 6.0 | Submission success rate: 5.0 Experience sharing:... (2023-11-11)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Journal of Zhejiang University-SCIENCE B]您好,您是該頁面的第 71154 位訪客。

期刊簡介
期刊名稱Journal of Zhejiang University-SCIENCE B Journal of Zhejiang University-SCIENCE B
LetPub Score
7.3
50 ratings
Rate

Reputation
8.3

Influence
5.9

Speed
8.7

期刊簡稱J ZHEJIANG UNIV-SC B
ISSN1673-1581
E-ISSN1862-1783
h-index45
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.700.8610.874
Subject fieldQuartilesRankPercentile
Category: Veterinary
Subcategory: General Veterinary
Q14 / 194
Category: Veterinary
Subcategory: General Pharmacology, Toxicology and Pharmaceutics
Q14 / 80
Category: Veterinary
Subcategory: General Biochemistry, Genetics and Molecular Biology
Q141 / 221

自引率 (2023-2024)14.90%自引率趨勢
掲載範囲
Journal of Zheijang University SCIENCE B - Biomedicine & Biotechnology is an international journal that aims to present the latest development and achievements in scientific research in China and abroad to the world’s scientific community.

JZUS-B covers research in Biomedicine and Biotechnology and Biochemistry and topics related to life science subjects, such as Plant and Animal Sciences, Environment and Resource etc.
官方網站https://www.springer.com/11585
在線稿件提交https://www.editorialmanager.com/zusb/
開放訪問No
出版商Zhejiang University Press
主題領域生物
出版國/地區PEOPLES R CHINA
發行頻率月刊
創刊年2005
每年文章數68每年文章數趨勢
黃金OA百分比3.03%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ170/313
BIOTECHNOLOGY & APPLIED MICROBIOLOGYSCIEQ129/174
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ147/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1673-1581%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 3.0 month(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【Journal of Zhejiang University-SCIENCE B】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 100.90
    CELLH-index: 705

    CiteScore: 110.00
    Molecular CancerH-index: 103

    CiteScore: 54.90
    Molecular PlantH-index: 85

    CiteScore: 37.60
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 27.10
    Molecular CellH-index: 356

    CiteScore: 26.00
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 24.50
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.30
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 24.70
    Nature Chemical BiologyH-index: 182

    CiteScore: 23.90
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules1302889
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS573494
    JOURNAL OF BIOLOGICAL CHEMISTRY396099
    NUCLEIC ACIDS RESEARCH340554
    CELL298451
    FASEB JOURNAL269330
    International Journal of Biological Sciences239658
    PLANT SCIENCE228275
    Molecular Cancer223881
    ONCOGENE203227
  •  

    Journal of Zhejiang University-SCIENCE B Journal of Zhejiang University-SCIENCE B
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [Journal of Zhejiang University-SCIENCE B] 的評論撰寫評論
作者: 西格丽德戈德温


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-11 18:42:34 評論於
Review speed: 6.0 | Submission success rate: 5.0
Experience sharing: This journal can only be described as rubbish. No movement in the review process for half a year, and then one day they tell you they can't find a reviewer
(0) 讚! | 西格丽德戈德温

作者: 0.0-992229


領域: 农林科学
審稿時間: 6.0 month(s)
結果: 拒稿


撰寫評論

2023-09-11 17:40:56 評論於
I also submitted for half a year, they said the content of the article was mediocre and had no specific suggestions, so they rejected it directly. What a waste of time
(0) 讚! | 0.0-992229

作者: rainninght


領域: 农林科学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2023-03-01 15:00:53 評論於
I don't think it has a direct relationship with the Chinese Dream of a Strong Nation. When the impact factor increases, it is a time when the impact factor of journals across the entire network is generally improving. In addition, there is a national support plan for scientific and technological journals. With the help of this plan, journals have been able to improve their impact factors through the joint efforts of the editorial department and all authors.
(0) 讚! | rainninght

作者: 寂灭恒鑫


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-23 23:34:54 評論於
Do you need the raw data?
(0) 讚! | 寂灭恒鑫

作者: 我滴小云云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-02 13:26:07 評論於
This trend of impact factor is clearly related to the dream of a strong nation, and the water is truly satisfying.
(6) 讚! | 我滴小云云

作者: 戴尔斯坦贝克


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-30 23:29:07 評論於
Actually, it's not bad. I just went about it the wrong way
(0) 讚! | 戴尔斯坦贝克

作者: 戴尔斯坦贝克


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-30 21:08:14 評論於
It's actually not bad, my bad, I just got the wrong method
(0) 讚! | 戴尔斯坦贝克

作者: 戴尔斯坦贝克


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-30 09:09:32 評論於
Actually, it's not bad. My problem was that I just approached it the wrong way
(0) 讚! | 戴尔斯坦贝克

作者: Abellona


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2022-05-06 20:06:33 評論於
Kiss, I would like to ask if there is any layout fee, and if so, how much is it?
(0) 讚! | Abellona

作者: Abellona


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2022-05-06 20:05:38 評論於
Kiss, I would like to ask if there is any layout fee and how much is the layout fee?
(0) 讚! | Abellona

作者: 泄矢香柏


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-18 10:33:59 評論於
Any experts here have read this magazine before? Is it any good?
(0) 讚! | 泄矢香柏

作者: 盗梦


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2022-02-04 17:31:11 評論於
One of the few conscientious journals in China. Recommended by a public account, I submitted an article with a trial mindset and received major revisions after a month. I was shocked at that time, as the editor provided over 70 comments on research content, logical writing, experimental design, image coordination, graphic issues, even paragraphs, and grammar. They also provided very detailed solutions, many of which were directly related to the key points, surprising in their professionalism. I spent another month revising based on the feedback, and felt that the quality of the article had greatly improved. The editorial team is composed of capable individuals, with fair and responsible editors. When encountering controversial issues, they provide opportunities for appeals and counter-arguments, and the processing is quite fast. I sent an email and received a reply in less than an hour. Zhejiang University has a distinctive approach in running this journal, unlike other magazines that require connections to submit papers. Currently, the journal's level is also suitable for domestic master's and PhD submissions. I just don't understand why it has been downgraded to the third tier. As of early February, the real-time impact factor has exceeded 5. As a promising national journal, shouldn't it be supported based on the principle of fairness during the classification by the Chinese Academy of Sciences? After all, this is one of the few comprehensive national journals. I wonder if certain magazines that rely on connections can be in the first tier, why can't this one even be in the second tier? Is it because they look down on Zhejiang University or what?
(92) 讚! | 盗梦

作者: 萧赢


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2022-01-25 15:38:34 評論於
2021.11.23 Initial submission, 12.6 Major revision, 12.16 Resubmission, 12.21 Acceptance. However, the typesetting took more than a month. The editor is very responsible, although it has been sent for AJE proofreading, the magazine will still make further modifications. Generally speaking, the magazine is very responsible. But it becomes more troublesome after acceptance, especially when importing references.
(14) 讚! | 萧赢

作者: 维尔娜菲茨杰拉德


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 21:54:47 評論於
Generally, the sections of a paper include title, abstract, introduction, methods, results, conclusion, figures (including figure titles and captions), acknowledgements, conflict of interest, and references
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 08:55:45 評論於
Usually, a research article is sufficient
(0) 讚! | 维尔娜菲茨杰拉德

作者: 修然小公主


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 14:37:28 評論於
What are the types of SCI articles that are more suitable for research novices to practice?
(0) 讚! | 修然小公主

作者: 北国博达


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 10:09:03 評論於
What are the major components of a research article?
(0) 讚! | 北国博达

作者: 初心未改


領域: 医学
審稿時間: 7.0 month(s)
結果: 拒稿


撰寫評論

2021-12-22 19:25:50 評論於
I just want to ask, this journal has been advertising for a year, claiming to be in the off-season every day. Now the 2021 rankings have been released, and it dropped from Zone 2 to Zone 3, yet it still claims to be in Zone 2 of the Chinese Academy of Sciences. The research it produces is originally a hot topic, but it has been delayed for half a year, and the feedback given is so amateurish. Can it be considered as supportive to you? (This journal once ranked in Zone 2 based on its impact factor of 3.)
(0) 讚! | 初心未改

作者: 初心未改


領域: 医学
審稿時間: 7.0 month(s)
結果: 拒稿


撰寫評論

2021-12-22 19:24:32 評論於
Let me tell you how this journal is like: I saw this journal doing advertisements, submitted an article, and it was reviewed and sent for review quickly by the editor. Then it entered a long review process, lasting 6 months, with no news at all. Seeing the sincerity in the writing (the next few months were the off-season for submissions, so the review was fast), I waited. However, after half a year passed, I was directly rejected, and the feedback seemed to be written by someone in the same field, with basically no valuable suggestions for revisions.
(5) 讚! | 初心未改

作者: 戴尔斯坦贝克


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-13 11:22:27 評論於
Review speed: 6.0 Experience sharing: It has been over three months and still no news. The advertisement said it would only take three days
(0) 讚! | 戴尔斯坦贝克

作者: 风陵英奕


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-09 10:31:31 評論於
Passing by a day of rejection
(0) 讚! | 风陵英奕

作者: 万花博硕


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-27 15:32:24 評論於
I've been job hunting for a month now, sigh
(0) 讚! | 万花博硕

作者: 戴尔斯坦贝克


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-15 17:23:39 評論於
Review speed: 6.0 | Submission acceptance rate: 25.0
Sharing experience: Extremely slow, it's been over 2 months and still no feedback for revisions
(0) 讚! | 戴尔斯坦贝克

作者: 戴尔斯坦贝克


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-13 18:25:14 評論於
Review speed: 6.0 | Submission hit rate: 25.0
Experience sharing: How dare this magazine advertise on the Princess Cruise that the review is fast, boasting to be as fast as 3 days for review, what a scam
(0) 讚! | 戴尔斯坦贝克

作者: ei


領域: 综合性期刊
審稿時間: 3.0 month(s)
結果: 拒稿


撰寫評論

2021-10-11 20:43:18 評論於
The speed from the editor's review to under review is relatively fast; however, it becomes particularly sluggish during the review stage. The reason for rejection feels somewhat evasive, as it is clearly a universally recognized information, but the reviewer questions the source of this information.
(1) 讚! | ei

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [Journal of Zhejiang University-SCIENCE B] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*